NR3C2 and glioblastoma: Intriguingly, while in patients with a GBM of classical or mesenchymal subtype lower NR3C2 expression correlated with poor survival (in the TCGA ‘classical’ dataset this did not reach statistical significance), the opposite was observed for the proneural subtype (Figure 3B–G).